Dental Care Clinics in Lake Village, AR Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Mainline Health Systems, Inc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 360 A Hwy 82, Lake Village, AR 71653 Phone: 870-201-2127 Fax: 888-671-8943 |
Chicot Memorial Medical Center Dental Clinic Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2729 S. Hwy 65 82, Lake Village, AR 71653 Phone: 870-265-5351 |
News Archive
Majority of pregnant women with depression not receiving treatment
The majority of pregnant women who have full-blown major depression aren't getting any treatment for the condition, and neither are most pregnant women who have signs of milder depression or depression risk.
EMA adopts positive opinion for Pfizer's bosutinib conditional approval in the EU
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Study finds football players may suffer from heat-related illness during first two weeks of practice
As the college football season heats up, a new University of Georgia study finds players are more likely to suffer from heat-related illness during the first two weeks of practice, especially those in the Southeast.
Older adults hospitalized for assault-related injuries more likely to suffer subsequent abuse
Older adults who have been hospitalized for injuries from an assault are more likely to experience subsequent physical abuse if they are female, widowed, diagnosed with dementia, or return home to live with the perpetrator, according to a new study in the Journal of the American Geriatrics Society.
Oxford BioTherapeutics, Menarini Group initiate phase I study of OBT357 (MEN1112) for AML treatment
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
› Verified 8 days ago